ArticleFrontiers in oncology2026

Case Report: Immune checkpoint inhibitor plus chemotherapy benefited an elderly patient with non-small cell lung cancer following EGFR-TKI resistance.

Zhiyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.